Reading between the lines!The comments below by Dr Saab indicates he has seen highly positive results from this Phase 2 trial. As the PI of the trial his comments carry enormous implications for ONC's future.
ONC has released a $150 million prospectus on Sedar. Does all this indicate that BT is going to go it alone?
"Saab said the results have been amazing so far, both slowing cancer growth and reducing the size of the tumor."
“What we have so far from individual observations suggests tremendous response to this virus when added to chemotherapy,” said Bekaii-Saab.